![Joseph Nixon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph Nixon
Directeur Financier/CFO chez Locus Biosciences, Inc.
Postes actifs de Joseph Nixon
Sociétés | Poste | Début | Fin |
---|---|---|---|
Bioaesthetics Corp.
![]() Bioaesthetics Corp. Miscellaneous Commercial ServicesCommercial Services Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA. | Directeur/Membre du Conseil | 23/08/2023 | - |
Locus Biosciences, Inc.
![]() Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Directeur Financier/CFO | - | - |
Historique de carrière de Joseph Nixon
Formation de Joseph Nixon
Case Western Reserve University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Commercial Services | 2 |
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Bioaesthetics Corp.
![]() Bioaesthetics Corp. Miscellaneous Commercial ServicesCommercial Services Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA. | Commercial Services |
Locus Biosciences, Inc.
![]() Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |
- Bourse
- Insiders
- Joseph Nixon
- Expérience